VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine RandD
GAITHERSBURG, Md., Dec. 27, 2021 -- (Healthcare Sales & Marketing Network) -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21 million in a Series A-1 round from six... Biopharmaceuticals, Venture Capital VLP Therapeutics, vaccine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Infectious Diseases | Marketing | Pharmaceuticals | Vaccines | Venture Capital